A NEW-GENERATION STARCH PRODUCT AS EXCIPIENT IN PHARMACEUTICAL TABLETS .3. PARAMETERS AFFECTING CONTROLLED DRUG-RELEASE FROM TABLETS BASED ON HIGH-SURFACE-AREA RETROGRADED PREGELATINIZED POTATO STARCH
Ghp. Tewierik et al., A NEW-GENERATION STARCH PRODUCT AS EXCIPIENT IN PHARMACEUTICAL TABLETS .3. PARAMETERS AFFECTING CONTROLLED DRUG-RELEASE FROM TABLETS BASED ON HIGH-SURFACE-AREA RETROGRADED PREGELATINIZED POTATO STARCH, International journal of pharmaceutics, 157(2), 1997, pp. 181-187
This paper describes the general applicability of a new pregelatinized
starch product in directly compressible controlled-release matrix sys
tems. It was prepared by enzymatic degradation of potato starch follow
ed by precipitation (retrogradation), filtration and washing with etha
nol. The advantages of the material include ease of tablet preparation
, the potential of a constant release rate (zero-order) for an extende
d period of time and the possibility to incorporate high percentages o
f drugs with different physicochemical properties. Constant release pr
ofiles are the result of solvent penetration into the tablet. For theo
phylline as test drug, constant release profiles could be realized up
to a drug content of 75%. This illustrates the possibility to control
the release of highly dosed drugs. Release rates from retrograded preg
elatinized starch tablets can be enhanced or decreased to the desired
profile by different parameters, like geometries of the tablet, compac
tion force and the incorporation of additional excipients. For procain
e HCl it is demonstrated that larger tablets show slower release rates
. The incorporation of soluble excipients like lactose and mannitol re
sults for paracetamol in enhanced release rates. The delivery of bases
and their salts can be modified by the incorporation of organic acid
or alkaline excipients, as is demonstrated for lidocaine and procaine
HCl. (C) 1997 Elsevier Science B.V.